Favorable Biology and Outcome of Stage IV-S Neuroblastoma With Supportive Care or Minimal Therapy: A Children’s Cancer Group Study
Top Cited Papers
- 1 February 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (3) , 477
- https://doi.org/10.1200/jco.2000.18.3.477
Abstract
PURPOSE: Stage IV-S neuroblastoma is a metastatic disease associated with spontaneous regression and good survival, but 10% to 20% of infants die from early complications. The purpose of this study...Keywords
This publication has 44 references indexed in Scilit:
- Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.Journal of Clinical Oncology, 1996
- Results of Pediatric Oncology Group Protocol 8104 for Infants with Stages D and DS NeuroblastomaJournal of Pediatric Hematology/Oncology, 1995
- Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.Journal of Clinical Oncology, 1993
- Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stageCancer, 1992
- The prognostic significance of age and pattern of metastases in stage IV-S neuroblastomaCancer, 1986
- IV‐S neuroblastoma: A cooperative study of 30 childrenMedical and Pediatric Oncology, 1983
- Do infants with stage IV-S neuroblastoma need treatment?Archives of Disease in Childhood, 1981
- A review of 17 IV-S neuroblastoma patients at the children's hospital of PhiladelphiaCancer, 1980
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971
- A proposed staging for children with neuroblastoma.Children's cancer study group ACancer, 1971